Journal
LIFE-BASEL
Volume 12, Issue 4, Pages -Publisher
MDPI
DOI: 10.3390/life12040525
Keywords
brain metastases; gender; health care level; lung cancer; palliative care; whole-brain radiotherapy
Categories
Funding
- Swedish Cancer Society [20_0675]
- Region Stockholm
Ask authors/readers for more resources
This study evaluates the healthcare levels and survival of lung cancer patients receiving whole-brain radiotherapy (WBRT) in Stockholm. The results show that patients have a short median survival, and a portion of them are unable to return home. There is a higher proportion of women who cannot come home.
Whole-brain radiotherapy (WBRT) as a treatment for brain metastases has been questioned over the last years. This study aimed to evaluate health care levels and survival after WBRT in a cohort of lung cancer patients with brain metastases receiving WBRT in Stockholm, Sweden, from 2008 to 2019 (n = 384). If the patients were able to come home again was estimated using logistic regression and odds ratios (OR) and survival by using Cox regression. The median age in the cohort was 65.6 years, the median survival following WBRT was 2.4 months (interquartile range (IQR) 1.2-6.2 months), and 84 (22%) patients were not able to come home after treatment. Significantly more males could come home again after WBRT compared to women (OR = 0.37, 95%CI 0.20-0.68). Patients with performance status scores WHO 3-4 had a median survival of 1.0 months, hazard ratio (HR) = 4.69 (95%CI 3.31-6.64) versus WHO score 0-1. Patients admitted to a palliative ward before WBRT had a median survival of 0.85 months, HR = 2.26 (95%CI 1.53-3.34) versus being at home. In conclusion, patients treated with WBRT had a short median survival and 20% could not be discharged from the hospital following treatment. Significantly more women did not come home again.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available